Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Prof Dr. Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Sonora | Mexico

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Simon Bernard Iloki Assanga embarked on his academic journey by obtaining a Bachelor's degree from the Pre-University Institute February 5 in Isle of Youth, Cuba, followed by a Graduate degree in Pharmaceutical Sciences from the University of Havana, Cuba. His academic pursuits culminated with a Doctorate in Pharmaceutical Sciences with a specialty in Immunology from the same institution in 2005.

Professional Endeavors

Dr. Assanga's professional career has been marked by a diverse array of roles, spanning from teaching to research. Noteworthy positions include his tenure as a Subject Teacher at the University of Sonora in Mexico, where he contributed to the Science department's Chemical-Biological sector. Additionally, he served as an Associate Full-Time Research Professor at the Department of Research and Postgraduate Studies in Food (DIPA) at the University of Sonora.

Contributions and Research Focus

Throughout his career, Dr. Assanga has made significant contributions to the field of pharmaceutical sciences and immunology. He has led various research projects, such as investigating the therapeutic potential of natural products for age-related macular degeneration and scaling up pilot plant production for nutraceuticals. His research interests also include exploring the chemical and nutritional composition of medicinal plants and their potential applications in healthcare.

Accolades and Recognition

Dr. Assanga's dedication and contributions have been recognized through numerous awards and honors. Notably, he received recognition for Outstanding Foreign Graduate from the Pharmacy Institute and Food at the University of Havana. He is also a member of prestigious scientific societies like the Society for Redox Biology and Medicine, highlighting his standing in the academic community.

Impact and Influence

Dr. Assanga's research, teaching, and participation in academic events have had a profound impact on the field of pharmaceutical sciences and immunology. His work in elucidating the therapeutic properties of natural products and mentoring students has contributed to advancements in healthcare and inspired future generations of researchers.

Legacy and Future Contributions

As a respected academic and researcher, Dr. Assanga's legacy lies in his extensive body of work, mentorship of aspiring scientists, and active participation in scientific discourse. His commitment to advancing knowledge in pharmaceutical sciences and immunology ensures that his contributions will continue to shape the field for years to come. In the future, he aims to further explore the therapeutic potential of natural products and collaborate on interdisciplinary research projects aimed at addressing pressing healthcare challenges.

Notable Publications

Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options 2023

Nutraceutical and dietary resources for breast cancer prevention – Highlighting strategies for suppressing breast aromatase expression 2023 (1)

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration 2022 (10)

Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass 2022 (11)

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity 2022 (20)

 

 

 

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

University of Messina | Italy

 Author Profile

Scopus

Early Academic Pursuits

Associate Professor Dr. Nicola Micale commenced his academic journey with an exceptional focus on Chemistry and Pharmaceutical Technology, culminating in an honored degree from the University of Messina. This foundation laid the groundwork for his specialization in pharmacology and pharmaceutical sciences.

Professional Endeavors

Micale's career trajectory has been marked by a series of esteemed positions, from pivotal research roles to impactful lectureships across Europe. His academic pursuits have extended globally, emphasizing collaborative research ventures and immersive academic experiences.

Contributions and Research Focus

Central to Micale's contributions is his intensive focus on neurodegenerative disorders and innovative drug design. His research spans diverse areas, ranging from peptidomimetics to targeted drug development, showcasing a commitment to combatting microbial infections and malignancies.

Accolades and Recognition

Micale's exemplary research earned him notable recognition, including the Farmindustria Award for Pharmaceutical Research and invitations to deliver lectures at prestigious international conferences. These accolades affirm his expertise and contributions to the field.

Impact and Influence

Beyond his research contributions, Micale's influence is evident through his pivotal roles on the editorial boards of multiple international scientific journals. His role as a reviewer for esteemed publications underscores his commitment to shaping scholarly dialogue and validating scientific research.

Legacy and Future Contributions

Associate Professor Dr. Nicola Micale's legacy is rooted in his multidisciplinary approach to pharmaceutical sciences and his dedication to fostering global scientific collaborations. His ongoing contributions are poised to drive advancements in pharmaceutical research, leaving a lasting imprint on the field's progression and innovation.

Notable Publications

Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses 2023 (6)

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M pro 2023 (5)

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors 2023 (3)